GW427353 (Solabegron), a Novel, Selective β3-Adrenergic Receptor Agonist, Evokes Bladder Relaxation and Increases Micturition Reflex Threshold in the Dog

@article{Hicks2007GW427353A,
  title={GW427353 (Solabegron), a Novel, Selective $\beta$3-Adrenergic Receptor Agonist, Evokes Bladder Relaxation and Increases Micturition Reflex Threshold in the Dog},
  author={Alexandra Hicks and Gerald P. McCafferty and Erin S. Riedel and Nambi V. Aiyar and Mark A. Pullen and Christopher Evans and Trudy D Luce and Robert W. Coatney and Gian C Rivera and Timothy D. Westfall and Jacob Paul Hieble},
  journal={Journal of Pharmacology and Experimental Therapeutics},
  year={2007},
  volume={323},
  pages={202 - 209}
}
Functional studies have demonstrated that adrenoceptor agonist-evoked relaxation is mediated primarily by β3-adrenergic receptors (ARs) in human bladder. Thus, the use of selective β3-AR agonists in the pharmacological treatment of overactive bladder is being explored. The present studies investigated the effects of a novel selective β3-AR agonist, (R)-3′-[[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethyl]amino]-[1,1′-biphenyl]-3-carboxylic acid (GW427353; solabegron) on bladder function in… Expand
An aryloxypropanolamine hβ3-adrenoceptor agonist as bladder smooth muscle relaxant.
  • S. Tasler, R. Baumgartner, +4 authors P. Ney
  • Chemistry, Medicine
  • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
  • 2012
TLDR
A ranking of hβ3-AR agonists by relative efficacy resulted in the closest analogy to the order of relaxation potential, with only the relaxant effect of mirabegron not reflecting its excellent relative efficacy as such. Expand
Beta3-Adrenoceptor Agonists: Possible Role in the Treatment of Overactive Bladder
TLDR
The β3-AR agonists are the most notable alternative class of agents to antimuscarinics in the pharmacological treatment of OAB and act to facilitate bladder storage function probably through at least two mechanisms: first, direct inhibition of the detrusor, and second, inhibition of bladder afferent neurotransduction. Expand
Beta 3-Adrenoceptor Agonists : Possible Role in the Treatment of Overactive Bladder
In the present review article, we present an overview of beta-adrenoceptor (β-AR) subtype expression at the mRNA and receptor protein levels in the human detrusor, the in vitro and in vivo bladderExpand
Functional investigation of β-adrenoceptors in human isolated detrusor focusing on the novel selective β3-adrenoceptor agonist KUC-7322
TLDR
Results suggest that KUC-7322 displays full agonistic activity in relaxing the human detrusor without inhibiting the contraction induced by cholinergic stimulation, which may be beneficial for the treatment of overactive bladder, as increased bladder capacity with a negligible effect on voiding contractions may be anticipated. Expand
Desensitization of cAMP Accumulation via Human β3-Adrenoceptors Expressed in Human Embryonic Kidney Cells by Full, Partial, and Biased Agonists
TLDR
It is concluded that a minor degree of efficacy for cAMP formation may be sufficient to induced full desensitization of that response and to detect ERK phosphorylation despite testing a wide variation of conditions. Expand
Functional BK channels facilitate the β3-adrenoceptor agonist-mediated relaxation of nerve-evoked contractions in rat urinary bladder smooth muscle isolated strips.
TLDR
It is found that BK channels play a critical role in the β3-adrenoceptor-mediated inhibition of rat DSM nerve-evoked contractions and there was a significant reduction in the BRL37344-induced inhibition of the 20 Hz EFS-induced contractions in rat DSM isolated strips. Expand
Pharmacological profile of β3-adrenoceptor agonists in clinical development for the treatment of overactive bladder syndrome
TLDR
The pharmacological profile ofβ3-Adrenoceptor agonists is reviewed and it appears that all three are strong agonists selective for β3- vs. β1- and β2-adrenoceptors in studies with cloned receptor subtypes. Expand
β-adrenoceptor agonist effects in experimental models of bladder dysfunction.
TLDR
Findings suggest that β₃-adrenoceptor agonists may become useful drugs for the treatment of bladder storage dysfunction, a view supported by recent phase III clinical studies for one such agent, mirabegron. Expand
Involvement of beta(3)-adrenoceptors in mouse urinary bladder function: role in detrusor muscle relaxation and micturition reflex.
TLDR
Based on the current results obtained using the beta(3)-adrenoceptor agonist CL316,243 (as well as various beta-adrenOceptor antagonists), functional beta( 3)-ad Renoceptors appear to be present in mouse urinary bladder. Expand
University of Groningen β3-Adrenoceptor detection and signal transduction: focus on antibody validation and urinary bladder
Chapter 8 Muscarinic receptor antagonists and β-adrenoceptor agonists are drug classes used in the treatment of both, obstructive airway disease and overactive bladder syndrome. Here we review theExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 43 REFERENCES
Characterization of β-adrenoceptor subtypes in the ferret urinary bladder in vitro and in vivo
Abstract In the present study, the β-adrenoceptor subtypes distributed in the detrusor of the ferret were investigated in functional experiments in vitro and in vivo using a variety of β-adrenoceptorExpand
Agonistic activity of SR59230A at atypical beta-adrenoceptors in guinea pig gastric fundus and duodenum.
TLDR
The results clearly indicate that SR59230A acts as an atypical beta-adrenoceptor agonist on guinea pig gastric fundus and duodenum. Expand
The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms.
TLDR
The positive chronotropic effects of isoproterenol, BRL 37344 and CGP 12177 were accompanied with a reduction in arterial blood pressure and the presence of a beta-3 adrenoceptor and its involvement in the control of heart rate was investigated in the dog. Expand
Characterization of beta-adrenoceptor subtypes in the ferret urinary bladder in vitro and in vivo.
TLDR
The present functional study provides the first evidence that relaxation of the ferret detrusor by beta-adrenoceptor activation is mediated mainly via the beta(3)-adrenOceptor, as in the humandetrusor. Expand
Characterization of beta-adrenoceptor subtype in bladder smooth muscle in cynomolgus monkey.
TLDR
The present functional study provides the first evidence that relaxation of the monkey detrusor by beta-adrenoceptor activation is mediated via the beta3-subtype. Expand
Functional identification of rat atypical β‐adrenoceptors by the first β3‐selective antagonists, aryloxypropanolaminotetralins
1 We have assessed the relative abilities of compounds belonging to the new aryloxypropanolaminotetralin (APAT) class and of the reference β‐adrenoceptor‐blocking agent, alprenolol, to antagonizeExpand
Functional identification of rat atypical beta-adrenoceptors by the first beta 3-selective antagonists, aryloxypropanolaminotetralins.
TLDR
Findings support APATs as the first potent, orally effective selective antagonists at beta 3-adrenoceptors, and provide final unambiguous evidence that beta 1 and 2 beta- adrenoceptor-blocking agents underlie inhibition of colonic motility and brown adipose tissue thermogenesis in rats. Expand
Functional Characterization of β-adrenoceptor Subtypes in the Canine and Rat Lower Urinary Tract
TLDR
In the dog the relaxing effects of isoprenaline in the distal urethra were about half those seen in the detrusor and trigone, and the maximal relaxation to each agonist wa... Expand
Effect of (R)-2-(2-Aminothiazol-4-yl)-4′-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} Acetanilide (YM178), a Novel Selective β3-Adrenoceptor Agonist, on Bladder Function
TLDR
The suitability of YM178 as a therapeutic drug for the treatment of symptoms of overactive bladder such as urinary frequency, urgency, and urge incontinence is suggested. Expand
Evidence for Pleiotropic Signaling at the Mouse β3-Adrenoceptor Revealed by SR59230A [3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol Oxalate]
This study examines the action of the β3-adrenoceptor antagonist SR59230A [3-(2-ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanoloxalate] at cloned mouse β3-adrenoceptorsExpand
...
1
2
3
4
5
...